Introduction: Patients on long-term hemodialysis are at a higher risk of cardiovascular disease and premature mortality. It is generally believed that omega-3 supplementation can prevent cardiovascular events due to its anti-inflammatory and anti-atherosclerotic effects.
Materials And Methods: Fifty-two hemodialysis patients were divided into 2 groups to receive omega-3 and placebo for 6 six months.